Legal News

EMA replies to open letter on coronavirus (COVID-19) vaccine concerns

Published on: 29 March 2021
Published by LNB News

LNB News 29/03/2021

Document Information

Issue Date: 29 March 2021

Published Date: 29 March 2021

Jurisdiction(s): United Kingdom

Article summary

The European Medicines Agency (EMA) has published its reply to an open letter from doctors and scientists expressing concerns regarding the Comirnaty, Moderna, and AstraZeneca coronavirus (COVID-19) vaccines. The reply contains detailed scientific responses to each of the queries listed in the open letter, such as information regarding the effect that the vaccine has on platelet counts and the steps taken to eliminate negative side effects in pre-clinical animal models prior to their approval for human use.

Popular documents